

557724 ·
BDB Bioscience · Cat: 557724
Reach 3+ verified distributors
Manufacturer product page
bdbiosciences.com/en-us/products/reagents/flow-cytometry-rea...
Description
Expression of IFN-gamma by stimulated CD4+ and CD4-BALB/c spleen cells. Splenocytes from BALB/C mice were stimulated for 4 hrs with PMA 5 ng/ml, Sigma Cat No P-8139 and Ionomycin 500 ng, Sigma Cat No I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with PE rat anti-mouse CD4 PE-RM4-5, Cat. No. 553048 and either rat anti-mouse IFN-gamma Alexa Fluor 488-XMG1.2, Cat. No. 557724 , left panel or immunoglobulin isotype control Alexa Fluor 488-R3-34, Cat. No. 557720 , right panel by using the BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of Alexa Fluor 488-XMG1.2 was blocked by preincubation of the fixed/permeabilized cells with an excess of unlabelled XMG1.2 antibody 5 mug, Cat. No. 554409, data not shown prior to stainining. The quadarant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls. Expression of IFN-gamma by stimulated CD4+ and CD4-BALB/c spleen cells. Splenocytes from BALB/C mice were stimulated for 4 hrs with PMA 5 ng/ml, Sigma Cat No P-8139 and Ionomycin 500 ng, Sigma Cat No I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with PE rat anti-mouse CD4 PE-RM4-5, Cat. No. 553048 and either rat anti-mouse IFN-gamma Alexa Fluor 488-XMG1.2, Cat. No. 557724 , left panel or immunoglobulin isotype control Alexa Fluor 488-R3-34, Cat. No. 557720 , right panel by using the BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of Alexa Fluor 488-XMG1.2 was blocked by preincubation of the fixed/permeabilized cells with an excess of unlabelled XMG1.2 antibody 5 mug, Cat. No. 554409, data not shown prior to stainining. The quadarant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls. Expression of IFN-gamma by stimulated CD4+ and CD4-BALB/c spleen cells. Splenocytes from BALB/C mice were stimulated for 4 hrs with PMA 5 ng/ml, Sigma Cat No P-8139 and Ionomycin 500 ng, Sigma Cat No I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with PE rat anti-mouse CD4 PE-RM4-5, Cat. No. 553048 and either rat anti-mouse IFN-gamma Alexa Fluor 488-XMG1.2, Cat. No. 557724 , left panel or immunoglobulin isotype control Alexa Fluor 488-R3-34, Cat. No. 557720 , right panel by using the BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of Alexa Fluor 488-XMG1.2 was blocked by preincubation of the fixed/permeabilized cells with an excess of unlabelled XMG1.2 antibody 5 mug, Cat. No. 554409, data not shown prior to stainining. The quadarant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls. Show More Expression of IFN-gamma by stimulated CD4+ and CD4-BALB/c spleen cells. Splenocytes from BALB/C mice were stimulated for 4 hrs with PMA 5 ng/ml, Sigma Cat No P-8139 and Ionomycin 500 ng, Sigma Cat No I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with PE rat anti-mouse CD4 PE-RM4-5, Cat. No. 553048 and either rat anti-mouse IFN-gamma Alexa Fluor 488-XMG1.2, Cat. No. 557724 , left panel or immunoglobulin isotype control Alexa Fluor 488-R3-34, Cat. No. 557720 , right panel by using the BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of Alexa Fluor 488-XMG1.2 was blocked by preincubation of the fixed/permeabilized cells with an excess of unlabelled XMG1.2 antibody 5 mug, Cat. No. 554409, data not shown prior to stainining. The quadarant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls. Show More Expression of IFN-gamma by stimulated CD4+ and CD4-BALB/c spleen cells. Splenocytes from BALB/C mice were stimulated for 4 hrs with PMA 5 ng/ml, Sigma Cat No P-8139 and Ionomycin 500 ng, Sigma Cat No I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with PE rat anti-mouse CD4 PE-RM4-5, Cat. No. 553048 and either rat anti-mouse IFN-gamma Alexa Fluor 488-XMG1.2, Cat. No. 557724 , left panel or immunoglobulin isotype control Alexa Fluor 488-R3-34, Cat. No. 557720 , right panel by using the BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of Alexa Fluor 488-XMG1.2 was blocked by preincubation of the fixed/permeabilized cells with an excess of unlabelled XMG1.2 antibody 5 mug, Cat. No. 554409, data not shown prior to stainining. The quadarant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls. Expression of IFN-gamma by stimulated CD4+ and CD4-BALB/c spleen cells. Splenocytes from BALB/C mice were stimulated for 4 hrs with PMA 5 ng/ml, Sigma Cat No P-8139 and Ionomycin 500 ng, Sigma Cat No I-0634 in the presence of Brefeldin A GolgiPlug, Cat. No. 555029 . Cells were harvested, fixed, permeabilized and stained with PE rat anti-mouse CD4 PE-RM4-5, Cat. No. 553048 and either rat anti-mouse IFN-gamma Alexa Fluor 488-XMG1.2, Cat. No. 557724 , left panel or immunoglobulin isotype control Alexa Fluor 488-R3-34, Cat. No. 557720 , right panel by using the BD Pharmingen staining protocol. To demonstrate specificity of staining the binding of Alexa Fluor 488-XMG1.2 was blocked by preincubation of the fixed/permeabilized cells with an excess of unlabelled XMG1.2 antibody 5 mug, Cat. No. 554409, data not shown prior to stainining. The quadarant markers for the bivariate dot plots were set based on the autofluorescence and isotype controls.







